Insider buying last 90 days
No open-market insider purchases were filed for WAT in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every WAT insider filing, plotted on the chart in Gekko.Open WAT in Gekko
Gekko Brief
Nov 4 closeWaters closed at $467.60 on 4 November 2026, +1.7% on the day. The price sits above both the 50-day ($433.00) and 200-day ($370.57) moving averages, inside a 52-week range of $282.77 to $482.28. The GekkoIndex reads 50.7, in the Neutral zone, up 4.4 points over five sessions. Gekko Fair Value is $364.29, so the price is 28.4% above it.
Over the last 8 reports the company beat the earnings estimate 8 times, with an average move of 9.3% across the report. Seasonally, the next 20 trading days from this point averaged +5.2% over the last 5 years, rising in 3 of them.
16 firms rate the stock: 12 buy, 4 hold and 0 sell, with a consensus target of $465.86. A typical daily move is about 3.6%, and a typical 20-day move about 5.6%. On the swing-trade checklist, 2 items read supportive and 1 reads as a headwind (fair value).
A plain summary of the figures as of the Nov 4, 2026 close.
Waters price vs fair value
Close $467.60200-day averageGekko Fair Value $364.29
Waters quick facts
- Market cap
- $45.91B
- P/E ratio
- 116.4
- Forward P/E
- 26.5
- EPS, TTM
- $3.95
- Revenue, TTM
- $4.64B
- Profit margin
- 3.6%
- Dividend yield
- —
- Beta
- 1.15
- Volume
- 1.09M avg 1.05M
- 1-year return
- +35.3%
- Typical daily move
- ±3.6%
- Typical 20-day move
- ±5.6%
- 50-day average
- $433.00
- 200-day average
- $370.57
- Next earnings
- —
- Shares outstanding
- 98.19M
Waters swing-trade checklist
Waters scores 2 supportive, 1 mixed and 1 headwind across the 4 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed1 headwind
- Trendsupportive
Above 50 and 200-day
Close $467.60 is above the 50-day ($433.00) and 200-day ($370.57) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
50.7, Neutral
Reading 50.7 is in the Neutral zone.
See the GekkoIndex - Fair valueheadwind
28.4% above
Price is 28.4% above Gekko Fair Value (more than 5% above).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskno data
No data
No confirmed report date on the calendar.
See earnings - Seasonalitysupportive
+5.2% on average
From this point in the calendar, the next 20 trading days averaged +5.2% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Waters stock chart and price history
Waters closed at $467.60 on Nov 4, 2026, +35.3% over the past year, inside a 52-week range of $282.77 to $482.28.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +7.1%
- 3 months
- +17.0%
- 6 months
- +33.8%
- 1 year
- +35.3%
The full WAT chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open WAT in Gekko
Follow Waters through every session
Put WAT on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track WAT in GekkoFree for 7 days. No credit card required.
About Waters
Waters makes precision instruments used to measure and analyze materials in laboratories around the world, serving customers across Asia, the Americas, and Europe. It is particularly known for its liquid chromatography and mass spectrometry systems, which laboratories rely on for tasks ranging from drug discovery to protein analysis, nutritional testing, and environmental screening. These systems are supported by related consumables, such as chromatography columns, along with service plans once warranties expire.
The company runs two segments. The Waters segment covers chromatography and mass spectrometry equipment, while the TA segment builds instruments for thermal analysis, rheometry, and calorimetry, used to test how materials like chemicals, polymers, metals, and pharmaceuticals behave and hold up under different conditions. Waters also produces software that works with its own instruments as well as equipment made by other companies. Its customers include organizations in life sciences, pharmaceuticals, biochemistry, industrial manufacturing, nutritional safety, environmental testing, academia, and government, who use its tools for research, quality control, and everyday lab work.
Founded in 1958 and based in Milford, Massachusetts, Waters is listed on the NYSE under the ticker WAT.
- Listed
- NYSE
- Sector
- Health technology
- Industry
- Medical specialties
- Website
- waters.com
Waters GekkoIndex: the smart money zone
Waters’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 50.7, in the Neutral zone, up 4.4 points over five sessions.
50.7Neutral
Up 4.4 points over five sessions.
Reading for Nov 4, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 47 | +1.2% | +4.3% | ||
| Accumulation | 159 | +0.8% | +2.1% | ||
| Neutral (current zone) | 445 | +0.4% | +1.1% | ||
| Distribution | 45 | −1.6% | −0.9% | ||
| Selling | 1 | Too few readings yet | |||
Average WAT share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the WAT price, zone by zone.Track WAT in Gekko
Is Waters stock overvalued? Gekko Fair Value
Waters trades 28.4% above Gekko Fair Value of $364.29, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Waters shares are worth, recalculated every trading day.
$364.29
Gekko Fair Value, Nov 4, 2026
28.4% Overvalued
At the end of Aug 2026 the price was 20.5% above the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open WAT in Gekko
Waters insider and Congress trading
No open-market insider purchases were filed for Waters, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in WAT were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for WAT, plotted on the chart in Gekko.Open WAT in Gekko
Buybacks
Waters has been buying back its own shares.
- Bought back, quarter ended Jul 4, 2026
- $2.00M
- As a share of market cap
- 0.00%
- Trailing four quarters
- $14.36M
From company filings.
Hedge funds and billionaires quarter ended Jun 30
3of the funds Gekko tracks hold WAT.
1added1opened1trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko
Waters earnings: next date and track record
Waters beat the EPS estimate in 8 of its last 8 reports, moving 9.3% on average across the report.
8 of 8reports beat the EPS estimate
±9.3%average move across the report
4 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Aug 4, 2026 AI summary
- What they said
- Waters Corporation reported Q2 2026 total revenue of $1.645 billion, with organic revenue of $828 million growing 9% in constant currency. The newly acquired Waters Bioscience and Diagnostic Solutions contributed $817 million, growing 4% versus prior year. Adjusted EPS grew 3% to $3.05, hitting the high end of guidance. All four divisions exceeded guidance, with pharma and academic/government end markets delivering double-digit growth for the second consecutive quarter.
- Guidance
- Management raised implied full-year confidence given Q2 outperformance of approximately 100 basis points above guidance range. Bioscience and Diagnostic Solutions revenue exceeded guidance by $15 million, with acceleration to mid-single-digit growth expected to continue as 180-day integration plan takes hold.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 4, 2026 | $3.05 est $3.01 | $1.65B est $1.62B | +6.7% |
| May 5, 2026 | $2.70 est $2.31 | $1.27B est $1.20B | +15.8% |
| Feb 9, 2026 | $4.53 est $4.51 | $932.4M est $928.3M | −14.2% |
| Nov 4, 2025 | $3.40 est $3.21 | $799.9M est $781.0M | +7.6% |
| Aug 4, 2025 | $2.95 est $2.94 | $771.3M est $748.7M | −3.1% |
| May 6, 2025 | $2.25 est $2.22 | $661.7M est $654.8M | −0.8% |
| Feb 12, 2025 | $4.10 est $4.03 | $872.7M est $857.1M | −6.5% |
| Nov 1, 2024 | $2.93 est $2.68 | $740.3M est $713.0M | +19.9% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Waters stock forecast and analyst price targets
Analysts’ average 12-month price target for Waters is $465.86, −0.4% from the last close, from 16 firms rating the stock in the last 90 days.
$465.86consensus 12-month target, −0.4% from the last close
Now $467.60Avg $465.86
Low $430High $536
Each firm’s latest rating in the last 90 days: 16 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 4 | Citi | $536 | +14.6% |
| Nov 4 | KeyBanc | $500 | +6.9% |
| Nov 4 | KeyBanc | $500 | +6.9% |
| Nov 4 | Stifel Nicolaus | $470 | +0.5% |
| Nov 4 | Robert W. Baird | $504 | +7.8% |
+1.1%average 20-day move after past Neutral readings
+5.2%average move over the next 20 trading days in the last 5 years
±3.6%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Waters seasonality: the next 20 trading days
Over the next 20 trading days from Nov 4, Waters averaged +5.2% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +2.3% | 3 of 5 |
| Next 10 trading days | −0.2% | 3 of 5 |
| Next 15 trading days | +4.5% | 3 of 5 |
| Next 20 trading days | +5.2% | 3 of 5 |
| Next 30 trading days | +6.8% | 4 of 5 |
For scale, WAT’s typical 20-trading-day move in either direction is about 5.6%.
Waters market cap and key statistics
Waters’s market cap is $45.91B, with a P/E ratio of 116.4 and revenue of $4.64B over the last twelve months.
Valuation
- Market cap
- $45.91B
- P/E ratio
- 116.4
- Forward P/E
- 26.5
- EPS, TTM
- $3.95
- Gekko Fair Value
- $364.29
Trading
- Volume
- 1.09M
- Avg volume, 20 days
- 1.05M
- 52-week high
- $482.28
- 52-week low
- $282.77
- Shares outstanding
- 98.19M
Financials
- Revenue, TTM
- $4.64B
- Profit margin
- 3.6%
- Return on equity
- 1.9%
- Quarterly earnings growth, YoY
- −3.1%
Risk and income
- Beta
- 1.15
- Typical daily move
- ±3.6%
- Typical 20-day move
- ±5.6%
Waters stock news this week
Coverage of Waters this week reads positive: 16 positive, 2 neutral and 0 negative headlines.
- Waters CEO Udit Batra Announces Acquisition of MOBILion Systems to Expand Proteomics and AI-Driven Research CapabilitiesINDIA New England News, Nov 4
- TD Cowen maintains Waters at Buy, raises price target to $530 from $515TradingView, Nov 4
- Waters buys MOBILion to push into the $2 billion LC-MS proteomics marketMarketScale, Nov 4
- Waters Growth Prospects Accelerating on Artificial Intelligence and Reshoring InitiativesMorningstar, Nov 4
- Waters Q3 Earnings Call HighlightsMarketBeat, Nov 4
- Why Is Waters Corporation Stock Gaining Tuesday? - Waters (NYSE:WAT)Benzinga, Nov 3
Waters peers
Waters’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Neutral | 14.5% above |
| ABTAbbott Laboratories | Distribution | 8.0% below |
| ISRGIntuitive Surgical | Distribution | 30.4% above |
| DHRDanaher | Neutral | 3.6% above |
| MDTMedtronic | Neutral | 16.0% below |
| SYKStryker | Distribution | 6.5% above |
A peer links to its own page where one exists.
Waters stock FAQ
What is Waters’s market cap?
Waters’s market cap is $45.91B at the Nov 4, 2026 close of $467.60, with 98.19M shares outstanding. The shares trade on a P/E ratio of 116.4.
What is the Waters stock forecast?
The consensus analyst 12-month price target for Waters is $465.86, −0.4% from the last close. Of the 16 firms that rated the stock in the last 90 days, 12 rate it a buy, 4 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Waters stock overvalued or undervalued?
On Gekko’s estimate Waters is overvalued: the Nov 4, 2026 close of $467.60 is 28.4% above Gekko Fair Value of $364.29. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
What is Waters’s 52-week high and low?
Waters’s 52-week high is $482.28 and its 52-week low is $282.77; it closed at $467.60 on Nov 4, 2026, +35.3% over the past year.
Is Waters stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 4 items with data read as supportive (trend and seasonality), 1 as mixed (gekkoindex) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Waters the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.